Visualization of brain amyloid and microglial activation in mouse models of alzheimer's disease

Current Alzheimer Research

Volumn 6, Issue 2, 2009, Pages 137-143

  Higuchi, Makoto ^a  

^a NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

Author keywords

A ; Amyloid; Imaging biomarker; Microglia; Positron emission tomography; Tau; Transgenic mouse

Indexed keywords

1 FLUORO 2,5 BIS(3 HYDROXYCARBONYL 4 HYDROXY)STYRYLBENZENE; AMYLOID; AMYLOID BETA PROTEIN; BIOLOGICAL MARKER; DAA 1106; DAA 1123; FLUORESCENT DYE; PITTSBURGH COMPOUND B; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; AMINO TERMINAL SEQUENCE; AMYLOIDOSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; IMMUNOTHERAPY; IN VITRO STUDY; MICROGLIA; MOUSE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MODIFICATION; REGULATORY MECHANISM; TRANSGENIC MOUSE;

ACETAMIDES; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; AMYLOID BETA-PROTEIN PRECURSOR; ANILINE COMPOUNDS; ANIMALS; AUTORADIOGRAPHY; BRAIN; BRAIN MAPPING; DISEASE MODELS, ANIMAL; HUMANS; ISOTOPES; MICE; MICE, TRANSGENIC; MICROGLIA; MUTATION; PHENYL ETHERS; POSITRON-EMISSION TOMOGRAPHY; PROTEIN BINDING; TAU PROTEINS; THIAZOLES;

EID: 64549127780     PISSN: 15672050     EISSN: None     Source Type: Journal    
DOI: 10.2174/156720509787602906     Document Type: Article

References (21)

1. Hardy J. Alzheimer's disease: the amyloid cascade hypothesis: an update and reappraisal. J Alzheimers Dis 9: 151-3 (2006).
2. Klunk WE, Engler H, Nordberg A, Wang Y, Blomqvist G, Holt DP, et al. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Ann Neurol 55: 306-19 (2004).
3. 11C]PIB in a nondemented population: potential antecedent marker of Alzheimer disease. Neurology 67: 446-452 (2006).
4. Rowe CC, Ng S, Ackermann U, Gong SJ, Pike K, Savage G, Cowie TF, et al. Imaging β-amyloid burden in aging and dementia. Neurology 68: 1718-25 (2007).
5. Scarpini E, Scheltens P and Feldman H. Treatment of Alzheimer's disease: current status and new perspectives. Lancet Neurol 2: 539-47 (2003).
6. Schenk D, Barbour R, Dunn W, Gordon G, Grajeda H, Guido T, et al. Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature 400: 173-7 (1999).
7. Morgan D, Diamond DM, Gottschall PE, Ugen KE, Dickey C, Hardy J, et al. Aβ peptide vaccination prevents memory loss in an animal model of Alzheimer's disease. Nature 408: 982-85 (2000).
8. Klunk WE, Lopresti BJ, Ikonomovic MD, Lefterov IM, Koldamova RP, Abrahamson EE, et al. Binding of the positron emission tomography tracer Pittsburgh compound-B reflects the amount of amyloid-β in Alzheimer's disease brain but not in transgenic mouse brain. J Neurosci 25: 10598-606 (2005).
9. 11C]6-OH-BTA-1, in a transgenic mouse model of Alzheimer's disease. Eur J Nucl Med Mol Imaging 32: 593-600 (2005).
10. Block ML, Zecca L and Hong JS. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat Rev Neurosci 8: 57-69 (2007).
11. Yoshiyama Y, Higuchi M, Zhang B, Huang SM, Iwata N, Saido TC, et al. Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model. Neuron 53: 337-51 (2007).
12. Sturchler-Pierrat C, Abramowski D, Duke M, Wiederhold KH, Mistl C, Rothacher S, et al. Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. Proc Natl Acad Sci USA 94: 13287-92 (1997).
13. Hsiao K, Chapman P, Nilsen S, Eckman C, Harigaya Y, Younkin S, et al. Correlative memory deficits, Aβ elevation, and amyloid plaques in transgenic mice. Science 274: 99-102 (1996).
14. Maeda J, Ji B, Irie T, Tomiyama T, Maruyama M, Okauchi T, et al. Longitudinal, quantitative assessment of amyloid, neuroinflammation and anti-amyloid treatment in a living mouse model of Alzheimer's disease enabled by positron emission tomography. J Neurosci 27: 10957-68 (2007).
15. 18F]fluoroethyl-5-methoxybenzyl)acetamide, for PET imaging of peripheral benzodiazepine receptor in primate brain. J Med Chem 47: 2228-35 (2004).
16. 1H MRI detection of amyloid β plaques in vivo. Nat Neurosci 8: 527-33 (2005).
17. Tai YC, Ruangma A, Rowland D, Siegel S, Newport DF, Chow PL, et al. Performance evaluation of the microPET focus: a third-generation microPET scanner dedicated to animal imaging. J Nucl Med 46: 455-63 (2005).
18. N3(pE), in senile plaques. Neuron 14: 457-66 (1995).
19. Hintersteiner M, Enz A, Frey P, Jaton AL, Kinzy W, Kneuer R, et al. In vivo detection of amyloid-β deposits by near-infrared imaging using an oxazine-derivative probe. Nat Biotechnol 23: 577-83 (2005).
20. Solomon B. Alzheimer's disease immunotherapy: from in vitro amyloid immunomodulation to in vivo vaccination. J Alzheimers Dis 9: 433-8 (2006).
21. Iwata N, Tsubuki S, Takaki Y, Shirotani K, Lu B, Gerard NP, et al. Metabolic regulation of brain Aβ by neprilysin. Science 292: 1550-2 (2001).